Malaria News and Research

Latest Malaria News and Research

Actor George Clooney contracts malaria

Oscar-winning actor George Clooney contracted malaria during a trip to Sudan earlier this month, but is now fully cured. Clooney, 49, had visited Sudan earlier and on this trip was helping draw attention to a historic referendum on independence for residents of the mainly Christian south.

20 Jan 2011

QBC Diagnostics releases ParaLens Advance to provide benefits of LED fluorescence microscopy

QBC Diagnostics is pleased to announce the release of the QBC ParaLens Advance, a breakthrough product that can easily upgrade any compound light microscope for LED fluorescence microscopy.

20 Jan 2011

Malaria parasite caught in action on film for the first time

Australian researchers have managed to take pictures of microscopic malaria parasite as it invades a human red blood cell. This will provide a deeper understanding of the parasite’s behaviour and may help fight it. Up to 10% of the world’s population contract malaria every year and a million people, mostly pregnant women and children, die as a result of the parasite transmitted by infected mosquitoes.

19 Jan 2011

Dr. Kathleen receives NSF grant to measure how climate change will impact risk of malaria, dengue fever

Thanks to a $250,000 National Science Foundation grant we may soon know how climate change will impact our risk of malaria and dengue fever. Dr. Kathleen Schreiber, professor of geography at Millersville University of Pennsylvania, received the grant from the NSF sponsored Vector-Borne Disease Project to measure how environmental temperature change influences the transmission and disease risk of the two diseases.

19 Jan 2011

WHO Director-General opens executive board session with calls for reform

Kicking off a nine-day annual WHO executive board meeting Monday, WHO Director-General Margaret Chan called for the board to consider areas where the agency can redirect resources in a more targeted manner so as to achieve greater outcomes, Reuters reports.

19 Jan 2011

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Harbor BioSciences, Inc., a leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals, announced it has licensed the research and development and commercialization rights for three of its products, exclusively in the People's Republic of China and Hong Kong, to China State Institute of Pharmaceutical Industry (CIPI).

18 Jan 2011

Media look at what's ahead for South Sudan

"This week's independence referendum in southern Sudan marks an apparent victory for U.S. foreign policy in east Africa - one that has secured for Washington a deeper advisory role in what is expected to be the birth of a new, impoverished nation," according to a Wall Street Journal article looking at the issues facing the U.S. in south Sudan after voting concludes.

18 Jan 2011

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

A Phase II trial published Friday in Lancet Infectious Diseases has shown that RTS,S, the "experimental malaria vaccine from GlaxoSmithKline provides African children with long-lasting protection" against malaria, Reuters reports.

18 Jan 2011

Opinions: U.S. HIV funding; Global fund accountability; World food supply

President Barack Obama's Global Health Initiative is "pitting AIDS against other diseases by making investments in new areas of global health contingent on flat funding for efforts to fight the HIV epidemic," HIV/AIDS advocate and Yale College student Gregg Gonsalves writes in a Washington Post opinion piece.

18 Jan 2011

CINJ clinical trial explores anti-malaria drug against melanoma

Building upon recent laboratory discoveries on resistance by cancer cells to therapies that attempt to starve cancer, scientists at The Cancer Institute of New Jersey (CINJ) are conducting a clinical trial that further explores how to prevent that action.

14 Jan 2011

News outlets examine reaction to WHO plan to contain drug-resistant malaria

In follow-up coverage of the WHO's announcement Wednesday of a plan to contain the spread of artemisinin-resistant malaria, news outlets examined the scope of the problem, reactions to the plan and speculations of how the anticipated $175 million annual cost would be funded.

14 Jan 2011

WHO, Roll Back Malaria partnership launch initiative to contain artemisinin-resistant malaria

The WHO and Roll Back Malaria partnership (RBM) on Wednesday launched an initiative to "stop a form of drug-resistant malaria from spreading from Southeast Asia to Africa, where millions of lives could be at risk," Reuters reports. "It would cost about $175 million a year to contain and prevent the global spread of the artemisinin-resistant parasite which first emerged along the Thai-Cambodian border in 2007, the United Nations agency said," according to the news agency (Nebehay, 1/12).

13 Jan 2011

Washington Post examines theories on climate change's potential impact on disease spread

The Washington Post examines the debate among scientists over the impact climate change might have on the spread of infectious diseases, and the potential for a rise in the number of tropical diseases in the U.S. The article describes how extreme weather conditions, such as flooding and drought - "thought to be linked to the warming of the oceans and to changes in the precipitation cycle" - can create ideal conditions for waterborne disease.

13 Jan 2011

Drug resistant malaria on the prowl

Experts have warned that drug-resistant malaria could spread from Southeast Asia to Africa within months, putting millions of children’s lives at risk. Nicholas White, professor of tropical medicine at Mahidol University in Bangkok warned that a malaria strain resistant to the drug artemisinin that first emerged along the Thai-Cambodian border in 2007.

12 Jan 2011

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

Inovio Pharmaceuticals, Inc., a leader in the development of novel therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive results from Inovio's multi-antigen Chikungunya virus (CHIKV) DNA vaccine in PLoS Neglected Tropical Diseases.

12 Jan 2011

Medical aid workers should take pre-travel precautions to prevent disease transmission

Guidance about pre-travel precautions and preventive measures are highlighted in the December 1, 2010 issue of Clinical Infectious Diseases, written by clinicians and researchers at the Uniformed Services University of the Health Sciences and their partners from the University of Texas Health Sciences Center, Naval Medical Research Center and others.

11 Jan 2011

Aid groups, U.N., U.S. discuss response to Haiti's earthquake as year anniversary approaches

On Friday, the Office of the U.N. Special Envoy to Haiti said that 63.6 percent of the aid international donors "pledged to Haiti in 2010 after a devastating earthquake nearly one year ago" has been disbursed, Deutsche Presse-Agentur/M&C reports (1/7).

11 Jan 2011

Positive preclinical results from Inovio's novel DNA vaccine targeting HIV Clade C virus

Inovio Pharmaceuticals, a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today the publication of a scientific paper highlighting positive preclinical results from Inovio's novel DNA vaccine targeting HIV Clade C viruses in the journal Vaccine.

10 Jan 2011

Malaria drug makes cancer drug more effective

Scientists investigating the cancer-fighting properties of artesunate - a drug commonly used to treat malaria - have found early evidence that combining it with an existing cancer drug has the potential to make each drug more effective than when used alone. They also found that regular treatment breaks could improve success levels.

7 Jan 2011

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, today announced that patient enrollment has begun in a multicenter, open-label clinical study of CMX001 (the CMX001-350 study) for the treatment of life-threatening or serious conditions caused by double-stranded DNA (dsDNA) viruses.

7 Jan 2011

Malaria News and Research

Latest Malaria News and Research

Actor George Clooney contracts malaria

QBC Diagnostics releases ParaLens Advance to provide benefits of LED fluorescence microscopy

Malaria parasite caught in action on film for the first time

Dr. Kathleen receives NSF grant to measure how climate change will impact risk of malaria, dengue fever

WHO Director-General opens executive board session with calls for reform

Harbor Biosciences signs development agreements for HE2000, HE3235 and HE3286 with CIPI

Media look at what's ahead for South Sudan

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

Opinions: U.S. HIV funding; Global fund accountability; World food supply

CINJ clinical trial explores anti-malaria drug against melanoma

News outlets examine reaction to WHO plan to contain drug-resistant malaria

WHO, Roll Back Malaria partnership launch initiative to contain artemisinin-resistant malaria

Washington Post examines theories on climate change's potential impact on disease spread

Drug resistant malaria on the prowl

PLoS Neglected Tropical Diseases features Inovio’s Chikungunya DNA vaccine

Medical aid workers should take pre-travel precautions to prevent disease transmission

Aid groups, U.N., U.S. discuss response to Haiti's earthquake as year anniversary approaches

Positive preclinical results from Inovio's novel DNA vaccine targeting HIV Clade C virus

Malaria drug makes cancer drug more effective

Chimerix initiates enrollment in CMX001 clinical study for life-threatening conditions caused by dsDNA viruses

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Malaria News and Research

Latest Malaria News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in